Abstract
Procedures recently published for a new European registration system will make a centralized or decentralized multi-state procedure mandatory in most circumstances. Although these changes will not come into being for several years, companies should gain experience with the current multi-state procedure before the new system becomes mandatory. This paper discusses the pros and cons of the procedure as it now exists and offers practical advice on using it through Sanofi's experience.
Get full access to this article
View all access options for this article.
